Defects in interferon signaling pathways have been suggested to induce mechanism of resistance to immunotherapy in prostate cancer cell lines [12] i.e., copy number deletion of IFN genes activates oncogenic pathways and repress immune signaling pathways by both promoting tumorigenesis and helping tumor cells to evade immunosurveillance [11]. Here, IFNA1 is linked to neoplasm.